Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem CellsBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousTransplantation ConditioningWhole-Body IrradiationStem Cell TransplantationLiver TransplantationTransplantation ChimeraGraft SurvivalBone and BonesStem CellsTissue DonorsLeukemiaAnemia, AplasticHematopoiesisBusulfanHistocompatibility TestingKidney TransplantationHistocompatibilityHematologic NeoplasmsBone Marrow PurgingTransplantation, IsogeneicMice, Inbred C57BLCyclophosphamideTreatment OutcomeRecurrenceCombined Modality TherapyImmunosuppressive AgentsTime FactorsCell DifferentiationLeukemia, Myeloid, AcuteBone Marrow DiseasesRadiation ChimeraColony-Forming Units AssayGraft RejectionLeukemia, Myelogenous, Chronic, BCR-ABL PositivePeripheral Blood Stem Cell TransplantationTransplantation ImmunologyRemission InductionAntigens, CD34Heart TransplantationHepatic Veno-Occlusive DiseaseHematopoietic Stem Cell MobilizationPrecursor Cell Lymphoblastic Leukemia-LymphomaCell TransplantationRetrospective StudiesCord Blood Stem Cell TransplantationLung TransplantationImmunosuppressionLeukemia, MyeloidLymphocyte DepletionMyelodysplastic SyndromesAcute DiseaseBone Marrow ExaminationHLA AntigensSevere Combined ImmunodeficiencySurvival AnalysisLymphoma, Non-HodgkinFlow CytometryT-LymphocytesCell LineageHematologic DiseasesOrgan TransplantationGraft vs Host ReactionCells, CulturedGraft vs Leukemia EffectBone Marrow NeoplasmsBlood CellsChimeraBone RemodelingLeukocyte TransfusionGranulocyte Colony-Stimulating FactorLymphocyte TransfusionMesenchymal Stem Cell TransplantationSurvival RateCyclosporineGraft vs Tumor EffectAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesChimerismCell SeparationMultiple MyelomaMelphalanCytomegalovirus InfectionsDisease-Free SurvivalLeukocyte CountActuarial AnalysisCarmustineCytarabineSpleenPancytopeniaTransplantationNuclear FamilyMice, KnockoutIslets of Langerhans Transplantation